These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 18361309)
1. Special considerations in the design, conduct and analysis of prophylaxis trials. Radhakrishna S Indian J Tuberc; 2008 Jan; 55(1):34-41. PubMed ID: 18361309 [TBL] [Abstract][Full Text] [Related]
3. Design and analysis of trials with rare outcomes: examples from trials in herpes transmission and influenza prophylaxis. Keene O Contemp Clin Trials; 2005 Jun; 26(3):311-22. PubMed ID: 15911465 [TBL] [Abstract][Full Text] [Related]
5. Assessing the validity of clinical trials. Akobeng AK J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):277-82. PubMed ID: 18728521 [TBL] [Abstract][Full Text] [Related]
6. Clinical trials and statistical analyses: what should dermatologists look for in a report? Alosh M; Fritsch K; Soukup M; Wilkin J Dermatol Ther; 2009; 22(3):199-203. PubMed ID: 19453343 [TBL] [Abstract][Full Text] [Related]
7. Design and analysis issues for economic analysis alongside clinical trials. Marshall DA; Hux M Med Care; 2009 Jul; 47(7 Suppl 1):S14-20. PubMed ID: 19536012 [TBL] [Abstract][Full Text] [Related]
8. Designing phase III or IV trials for vaccines: choosing between individual or cluster randomised trial designs. Vaucher P Vaccine; 2009 Mar; 27(13):1928-31. PubMed ID: 19368773 [TBL] [Abstract][Full Text] [Related]
9. The scientific basis of clinical trials: statistical aspects. Gehan EA Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2587-90. PubMed ID: 9815661 [TBL] [Abstract][Full Text] [Related]
10. A primer on the design, conduct, and interpretation of clinical trials. Appel LJ Clin J Am Soc Nephrol; 2006 Nov; 1(6):1360-7. PubMed ID: 17699370 [TBL] [Abstract][Full Text] [Related]
11. Strengthening gynecologic cancer prevention studies. Hill DA Obstet Gynecol Clin North Am; 2007 Dec; 34(4):639-50, vii. PubMed ID: 18061861 [TBL] [Abstract][Full Text] [Related]
12. Interpreting HIV clinical trials. Glesby MJ AIDS Clin Care; 1999 Jul; 11(7):58-9. PubMed ID: 11366435 [TBL] [Abstract][Full Text] [Related]
13. Global benefit-risk assessment in designing clinical trials and some statistical considerations of the method. Pritchett YL; Tamura R Pharm Stat; 2008; 7(3):170-8. PubMed ID: 17538942 [TBL] [Abstract][Full Text] [Related]
14. [Therapy research in times of patient preference]. Lüdtke R Z Arztl Fortbild Qualitatssich; 2005; 99(4-5):279-84. PubMed ID: 16044785 [TBL] [Abstract][Full Text] [Related]
15. Preventive misconception: its nature, presence, and ethical implications for research. Simon AE; Wu AW; Lavori PW; Sugarman J Am J Prev Med; 2007 May; 32(5):370-4. PubMed ID: 17478261 [TBL] [Abstract][Full Text] [Related]
16. [Statistical notes. Randomized controlled clinical trials of both superiority and non-inferiority: critical considerations]. Marubini E; Rebora P; Reina G Ital Heart J Suppl; 2005 Jun; 6(6):361-4. PubMed ID: 16013427 [TBL] [Abstract][Full Text] [Related]
17. Assessment of risk of bias in randomized clinical trials in surgery. Gurusamy KS; Gluud C; Nikolova D; Davidson BR Br J Surg; 2009 Apr; 96(4):342-9. PubMed ID: 19283747 [TBL] [Abstract][Full Text] [Related]